Table 2.
Projections of deaths and incidence and prevalence of metastatic cancer including de novo and recurrent metastatic disease in the United States for 2025a
| Cancer type | Projected number in US population in 2025 | Projected number of cancer deaths | Projected number of new metastatic (de novo and recurrence) cancer cases (incidence) | Projected number of individuals living with metastatic disease (de novo and recurrence) on January 1, 2025 (prevalence) |
|---|---|---|---|---|
| Lung and bronchus | 344 114 571 | 104 363 | 110 132 | 160 743 |
| Breast (female) | 174 407 303 | 41 434 | 52 126 | 169 347 |
| Colon and rectum | 344 114 571 | 47 355 | 56 227 | 149 840 |
| Prostate (male) | 169 707 268 | 29 567 | 50 055 | 156 812 |
| Melanoma | 344 114 571 | 3900 | 4810 | 38 691 |
| Bladder | 344 114 571 | 14 826 | 16 720 | 18 019 |
a
Estimates are presented for males and females together (all ages) unless otherwise specified.